Remove Drugs Remove Marketing Remove Medicine Remove Research Analyst
article thumbnail

Outsourcing Peptide Synthesis: Preferred Choice of Drug Developers

Roots Analysis

The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.

article thumbnail

Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding

The Pharma Data

The drugmakers lost out to domestic producers, which in some cases undercut prices for established medicines by more than 90%, according to Jiemian. Among the drugs to lose contracts were Eli Lilly schizophrenia medicine Zyprexa and Pfizer’s Viagra, the publication said. Virtual Event. DEVELOP A UNIFIED SCIENTIFIC VOICE.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BioSpace Movers & Shakers, Jan. 1

The Pharma Data

Reimer replaces Charlotte Russel and will be responsible for Alligator’s drug development candidates, with an emphasis on bringing mitazalimab and ATOR-1017 into Phase II efficacy studies. Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector.

article thumbnail

Novotech Health Holdings Appoints Zidong Zhang as CFO

The Pharma Data

Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. in its healthcare practice and conducted postdoctoral research in diabetes-related drug development at Boston University’s School of Medicine. ” ABOUT NOVOTECH HEALTH HOLDINGS.

article thumbnail

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.

article thumbnail

Outsourcing Antibody Discovery Process: The Profit-Driven Approach to Research

Roots Analysis

This helps to speed up the process of making new medicines and finding cures for diseases. With the rising demand for antibody therapeutics in the recent past, the domain of antibody discovery has seen a significant market growth towards outsourcing.